Automated digital uroflowmetry for office and home use

Ended Project Grant Awarded Last action

Award ID
R44DK127835
Recipient
Awarding agency
Obligated
$5,721,982

Award facts

Completion date
Originally
Funding
  • $5,111,970.00 Federal
  • $610,012.00 Non-federal
Place of performance
South Heidelberg Township, PA 19608, USA

Award details come from USAspending.gov.

Description

Abstract
Uroflowmetry is the most common urodynamic test performed by urologists to assess the function of the lower urinary tract. This simple non-invasive study measures urinary flow rates and when summarized graphically offers insights into various types of lower urinary tract symptoms. Current systems call upon a patient to void into a commode with a funnel to direct the flow of urine into a vessel placed on a digital scale which in turn drives its output into a processor. The processor is connected to a printer which produces summary data such as voided volume, peak flow, average flow, total void time, as well as a graphical representation of the flow curve anywhere from 20-30 seconds after the void is initiated or completed. The physician or their assistant will then empty the vessel, and the system can be used again. Traditionally the paper containing the printed collected data was filed into a paper chart. Today this tracing is taped to a 2ND paper containing the patient's name and medical record number, and this is scanned into the electronic record as an image and the data become non-searchable. Given this labor intense process, conventional uroflowmetry is ripe for disruptive innovation. We offer a hardware and software solution to these logistical problems. At this time our patent pending prototype uroflowmeter offers the following benefits: 1) IT can be used with any regular toilet (meaning IT can be used in an office setting or at home, and IT can be used by both males and females), 2) IT empties itself, and 3) the data are acquired in real time, and collected on a smart phone or tablet. In this application we seek support to develop the software that will allow this device to drive its data elements and the graphical summary into a set flowsheet in the electronic medical record where all uroflows will be stored. This will allow for a physician to review multiple flows over time to monitor a patient's progress without having to open up each individual image. Once this system is fully operational we envision this system being used in office and home settings, and playing a role in drug trials that assess lower urinary tract symptoms. The instantaneous detection of flow rate also means IT has the potential for future applications in biofeedback training for selected patients with specific lower urinary tract symptoms.

Transactions

Action Federal Non-federal Date
Amendment $879,432 $0
Amendment $879,432 $0
Amendment Digital uroflowmetry for office and home $889,432 $0
Amendment $0 $0
Amendment Digital uroflowmetry for office and home $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $621,825 $0
Amendment $621,825 $0
Amendment $610,012 $0
Original award $610,012 $610,012
Show all 13

Quick answers

Who received award R44DK127835?

R44DK127835 was awarded to Urogenie LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on April 1, 2021.

How much is award R44DK127835 worth?

$5,721,982 has been obligated on R44DK127835: $5,111,970 in federal funding and $610,012 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award